![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DM Novick, M Ochshorn, V Ghali, TS Croxson, WD Mercer, N Chiorazzi and MJ Kreek
Rockefeller University, New York, New York.
We studied natural killer (NK) activity and lymphocyte subsets in 11 active parenteral heroin abusers, 11 long-term methadone-maintained former heroin abusers and 11 apparently healthy individuals. All subjects were males aged 23 to 49 and none had active infectious or inflammatory diseases. All current or former heroin abusers were seronegative for antibody to human immunodeficiency virus. The methadone maintenance patients were socially rehabilitated and had not abused drugs parenterally for at least 10 years. NK activity was determined by a standard Cr-release cytotoxicity assay using K562 cells as targets, and lymphocyte subsets were determined by direct immunofluorescence using flow cytometry. At all three effector-target ratios (100:1, 50:1 and 25:1), NK activity was reduced significantly (P less than .01) in parenteral heroin abusers compared with methadone maintenance patients and apparently healthy individuals. The latter two groups did not differ from each other. Parenteral heroin abusers also had higher absolute numbers of CD2, CD3, CD4 and CD8-positive cells. These data support our hypothesis that significant abnormalities of cellular immunity in parenteral heroin abusers can be normalized by successful long-term methadone treatment.
This article has been cited by other articles:
|
|
 |
|
  D. Scott-Algara, L. X. Truong, P. Versmisse, A. David, T. T. Luong, N. V. Nguyen, I. Theodorou, F. Barre-Sinoussi, and G. Pancino Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users J. Immunol., December 1, 2003; 171(11): 5663 - 5667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Zhang, D. Hodge, T. J. Rogers, and J. J. Oppenheim Ca2+-independent Protein Kinase Cs Mediate Heterologous Desensitization of Leukocyte Chemokine Receptors by Opioid Receptors J. Biol. Chem., April 4, 2003; 278(15): 12729 - 12736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-J. Collett Chronic opioid therapy for non-cancer pain Br. J. Anaesth., July 1, 2001; 87(1): 133 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Kling, R. E. Carson, L. Borg, A. Zametkin, J. A. Matochik, J. Schluger, P. Herscovitch, K. C. Rice, A. Ho, W. C. Eckelman, et al. Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1070 - 1076. [Abstract] [Full Text]
|
|
|
|
|
|
P. Govitrapong, T. Suttitum, N. Kotchabhakdi, and T. Uneklabh Alterations of Immune Functions in Heroin Addicts and Heroin Withdrawal Subjects J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 883 - 889. [Abstract] [Full Text]
|
|
|
|
 |
|
 M.C. Grimm, A. Ben-Baruch, D.D. Taub, O.M.Z. Howard, J.H. Resau, J.M. Wang, H. Ali, R. Richardson, R. Snyderman, and J.J. Oppenheim Opiates Transdeactivate Chemokine Receptors: delta and µ Opiate Receptor-mediated Heterologous Desensitization J. Exp. Med., July 20, 1998; 188(2): 317 - 325. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
